Eli Lilly and Company
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
US
IE
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Eli Lilly and Company (LLY) Business News
Track Eli Lilly and Company in real time with a live news feed covering Eli Lilly and Company stock news, official press releases, company announcements, and an archive of historical Eli Lilly and Company news. ...more
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
India's 'Mounjaro brides': weight-loss injections become part of pre-wedding preparation
Eli Lilly (LLY) Stock Sinks As Market Gains: Here's Why
Market Today: Oil Jumps, SpaceX IPO, Tariff Shock
Trump Administration Unveils Up to 100% Tariff on Branded Drugs
MSFT, AVGO, LLY & Other Stock Market Opportunities Amid U.S.-Iran War
Global pharma companies that have publicly announced Trump drug pricing agreements
Novo Nordisk Releases Data Showing 3.2% Greater Weight Loss vs Lilly Pill
Eli Lilly Stock Slips Despite Foundayo Approval As Geopolitical Tensions Weigh
Lilly Pushes Back on Making Drug Price Deals Permanent
Lilly (LLY) Surges 3.8%: Is This an Indication of Further Gains?
Wall Street sees multi-billion dollar debut for Lilly's obesity pill despite Novo lead
Prediction: This Will Be Eli Lilly's Next Billion-Dollar Growth Driver. (Hint: It's Not Weight Loss Drugs.
Eli Lilly and Company Target of Unusually Large Options Trading (NYSE:LLY)
Eli Lilly Stock Slips Despite Foundayo Approval As Geopolitical Tensions Weigh
Lilly Pushes Back on Making Drug Price Deals Permanent
Lilly (LLY) Surges 3.8%: Is This an Indication of Further Gains?
Wall Street sees multi-billion dollar debut for Lilly's obesity pill despite Novo lead
Prediction: This Will Be Eli Lilly's Next Billion-Dollar Growth Driver. (Hint: It's Not Weight Loss Drugs.
Eli Lilly and Company Target of Unusually Large Options Trading (NYSE:LLY)
Eli Lilly Jumps After Winning FDA Approval For Obesity Pill
Eli Lilly Stock Jumps. A Weight-Loss Pill Is Officially on the Market.
Lilly's weight-loss pill wins US approval
The FDA approved Eli Lilly's new weight-loss pill, setting up a fight with rival Novo Nordisk over the next front in the booming market
India's 'Mounjaro brides': weight-loss injections become part of pre-wedding preparation
9:01 PM | Thursday | Apr 2, 2026
Soon-to-be brides and grooms seeking shortcuts to shed pounds before the big day have become the latest consumer target for weight-loss drugs in India.
Read full article
India's 'Mounjaro brides': weight-loss injections become part of pre-wedding preparation
ReutersSoon-to-be brides and grooms seeking shortcuts to shed pounds before the big day have become the latest consumer target for weight-loss drugs in India.
Read full article
Eli Lilly (LLY) Stock Sinks As Market Gains: Here's Why
Zacks Investment ResearchIn the most recent trading session, Eli Lilly (LLY) closed at $935.58, indicating a -1.98% shift from the previous trading day.
Read full article
Market Today: Oil Jumps, SpaceX IPO, Tariff Shock
GuruFocusGuru Stock PicksRichard Pzena has made the following transactions:Add in AMWD by 42.89%Private Capital has made the following transactions:Add in TH by 13.25%St
Read full article
Trump Administration Unveils Up to 100% Tariff on Branded Drugs
WSJDrugmakers or countries that strike pricing deals or make manufacturing investment commitments in the U.S. can secure much lower levies, or none at all.
Read full article
MSFT, AVGO, LLY & Other Stock Market Opportunities Amid U.S.-Iran War
Schwab NetworkThere's always opportunity in markets if you know where to look, says Tiffany McGhee. She offers insight into how her firm positions portfolios in times of profound volatility, including now as the U.S.-Iran War drags on.
Read full article
Global pharma companies that have publicly announced Trump drug pricing agreements
ReutersU.S. President Donald Trump secured agreements with 16 major pharmaceutical companies to bring U.S. prescription drug prices in line with those paid in other developed nations in exchange for three-year exemptions from tariffs on drug imports.
Novo Nordisk Releases Data Showing 3.2% Greater Weight Loss vs Lilly Pill
GuruFocusEli Lilly (LLY) has secured FDA approval for its oral obesity therapy, Foundayo, pushing the company deeper into the next phase of weight-loss treatment as pill
Read full article
Eli Lilly Stock Slips Despite Foundayo Approval As Geopolitical Tensions Weigh
BenzingaEli Lilly And Company (NYSE: LLY) shares are down approximately 1% Thursday despite FDA approval of its oral weight-loss drug Foundayo on Wednesday, as geopolitical tensions weigh on broader markets.
Read full article
Lilly Pushes Back on Making Drug Price Deals Permanent
GuruFocusEli Lilly (LLY, Financials) is drawing a clear line in the ongoing debate over drug pricing, warning that making current agreements permanent could create bigge
Read full article
Lilly (LLY) Surges 3.8%: Is This an Indication of Further Gains?
Zacks Investment ResearchLilly (LLY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Read full article
Wall Street sees multi-billion dollar debut for Lilly's obesity pill despite Novo lead
ReutersEli Lilly's newly approved weight-loss pill is expected to generate billions in sales as soon as this year, with analysts betting it will quickly narrow Novo Nordisk's head start in the oral market.
Read full article
Prediction: This Will Be Eli Lilly's Next Billion-Dollar Growth Driver. (Hint: It's Not Weight Loss Drugs.
The Motley FoolEli Lilly has captured investors' attention in recent times thanks to its blockbuster weight loss drugs. The company dominates this valuable market in the U.S.
Read full article
Eli Lilly and Company Target of Unusually Large Options Trading (NYSE:LLY)
Defense WorldEli Lilly and Company (NYSE: LLY - Get Free Report) was the target of some unusual options trading on Wednesday. Stock investors acquired 50,761 call options on the company. This represents an increase of 30% compared to the average daily volume of 39,145 call options. Wall Street Analyst Weigh In Several equities analysts recently issued reports
Read full article
Eli Lilly Stock Slips Despite Foundayo Approval As Geopolitical Tensions Weigh
BenzingaEli Lilly And Company (NYSE: LLY) shares are down approximately 1% Thursday despite FDA approval of its oral weight-loss drug Foundayo on Wednesday, as geopolitical tensions weigh on broader markets.
Read full article
Lilly Pushes Back on Making Drug Price Deals Permanent
GuruFocusEli Lilly (LLY, Financials) is drawing a clear line in the ongoing debate over drug pricing, warning that making current agreements permanent could create bigge
Read full article
Lilly (LLY) Surges 3.8%: Is This an Indication of Further Gains?
Zacks Investment ResearchLilly (LLY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Read full article
Wall Street sees multi-billion dollar debut for Lilly's obesity pill despite Novo lead
ReutersEli Lilly's newly approved weight-loss pill is expected to generate billions in sales as soon as this year, with analysts betting it will quickly narrow Novo Nordisk's head start in the oral market.
Read full article
Prediction: This Will Be Eli Lilly's Next Billion-Dollar Growth Driver. (Hint: It's Not Weight Loss Drugs.
The Motley FoolEli Lilly has captured investors' attention in recent times thanks to its blockbuster weight loss drugs. The company dominates this valuable market in the U.S.
Read full article
Eli Lilly and Company Target of Unusually Large Options Trading (NYSE:LLY)
Defense WorldEli Lilly and Company (NYSE: LLY - Get Free Report) was the target of some unusual options trading on Wednesday. Stock investors acquired 50,761 call options on the company. This represents an increase of 30% compared to the average daily volume of 39,145 call options. Wall Street Analyst Weigh In Several equities analysts recently issued reports
Read full article
Eli Lilly Jumps After Winning FDA Approval For Obesity Pill
Investors Business DailyEli Lilly stock jumped midday Wednesday after the Food and Drug Administration approved its weight-loss pill, now called Foundayo.
Read full article
Eli Lilly Stock Jumps. A Weight-Loss Pill Is Officially on the Market.
BarronsEli Lilly's Foundayo will be available to patients through the drugmaker's online pharmacy.
Read full article
Lilly's weight-loss pill wins US approval
ReutersThe U.S. Food and Drug Administration on Wednesday approved Eli Lilly's weight-loss pill, making it the second to market after Novo Nordisk's oral Wegovy, as the companies fight to capture more customers with the convenience of pills over injectables.
Read full article
The FDA approved Eli Lilly's new weight-loss pill, setting up a fight with rival Novo Nordisk over the next front in the booming market
WSJThe FDA go-ahead tees up a battle with rival Novo Nordisk over the next front in the booming weight-loss drug market.
Read full article